ICER Pushes ALS Drug Makers To Moderate Launch Price While Awaiting Confirmatory Data

 
• By Jessica Merrill
  
value versus price
ICER issued a final assessment on ALS drugs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip